Study of Microstructured Bioceramic Implants for Repairing Bone Defects in Adults Aged 18 to 65

What this Trial Is About

This research aims to demonstrate how bioceramic implants affect the repair of human bone defects and to explore their use in bone defects, implantation, and fusion. The focus is on b2-tricalcium phosphate bioceramic implants, whose surface microstructure can be controlled to guide bone regeneration, promote bone restoration, speed up recovery, and improve bone quality, which has important clinical and social significance. Participants will receive either commercial bone implant products available in the market, such as artificial or allogeneic bones with smooth surfaces, or b2-tricalcium phosphate bioceramic implants featuring microstructures like grooves and patterns. These bioceramic materials have excellent compatibility with the body and properties that encourage bone growth and guidance, providing mechanical strength comparable or superior to human cancellous bone. During the study, participants will be monitored over 12 months to assess the quality of life using the SF-36 questionnaire and the level of bone healing. Researchers will evaluate how well the implants support bone repair and recovery. Participants must communicate well and follow study requirements, with safety and effectiveness carefully tracked throughout the trial period.

Efficacy of Bioceramic Materials for Bone Defects Repair